Literature DB >> 16916591

Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia.

Yi-Hao Yen1, Jing-Houng Wang, Sheng-Nan Lu, Tai-Yi Chen, Chi-Sin Changchien, Chien-Hung Chen, Chao-Hung Hung, Chuan-Mo Lee.   

Abstract

BACKGROUND: To determine the utility of contrast-enhanced ultrasonography (CEUS) in assessing hepatic tumors with central feeding arteries found by color/power Doppler ultrasonograophy (CDUS/PDUS).
METHODS: We prospectively studied 37 hepatic tumors (34 patients), with a mean size of 2.9cm and each having a central feeding artery, by CDUS/PDUS. The CEUS was performed with a galactose-based microbubble contrast agent. The detection of a spoke-wheel sign was interpreted as evidence of focal nodular hyperplasia (FNH). All patients underwent tumor biopsies or surgical resection.
RESULTS: CEUS showed a central feeding artery with a spoke-wheel sign in 36 tumors, including 34 FNHs and 2 hepatocellular carcinomas. The remaining tumor was demonstrated to be FNH despite the absence of a spoke-wheel sign as detected by CEUS. The sensitivity of the spoke-wheel sign or central scar for FNH was 97.1% (34/35), 40% (14/35), 28.6% (10/35), 50% (8/16) and 0% (0/15) for CEUS, CDUS/PDUS, dynamic computed tomography (CT) or magnetic resonance imaging (MRI), hepatic angiography and liver scintigraphy, respectively. The two hepatocellular carcinomas showed scirrhous changes histologically.
CONCLUSIONS: CEUS is more sensitive than CDUS/PDUS, dynamic CT, MRI, hepatic angiography and liver scintigraphy in the detection of the spoke-wheel sign or central scar in FNH. Scirrhous hepatocellular carcinoma should be included in the differential diagnosis for liver tumors with spoke-wheel sign detected by CEUS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916591     DOI: 10.1016/j.ejrad.2006.06.007

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  12 in total

1.  Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies.

Authors:  Wen Luo; Kazushi Numata; Manabu Morimoto; Akito Nozaki; Michio Ueda; Masaaki Kondo; Satoshi Morita; Katsuaki Tanaka
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.

Authors:  Grace Lai-Hung Wong; Hui-Xiong Xu; Xiao-Yan Xie
Journal:  World J Radiol       Date:  2009-12-31

3.  A case of focal nodular hyperplasia with a new characteristic finding on contrast-enhanced ultrasonography using Levovist.

Authors:  Kaoru Onoue; Yukio Miyamoto; Makiko Nishioka; Norio Nakata; Toru Sekiya; Kunihiko Fukuda
Journal:  J Med Ultrason (2001)       Date:  2012-07-18       Impact factor: 1.314

4.  Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT.

Authors:  Wei Wang; Li-Da Chen; Ming-De Lu; Guang-Jian Liu; Shun-Li Shen; Zuo-Feng Xu; Xiao-Yan Xie; Yan Wang; Lu-Yao Zhou
Journal:  Eur Radiol       Date:  2013-04-27       Impact factor: 5.315

5.  Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.

Authors:  Kazuya Sugimori; Kazushi Numata; Masahiro Okada; Hiromi Nihonmatsu; Shigeo Takebayashi; Shin Maeda; Masayuki Nakano; Katsuaki Tanaka
Journal:  J Med Ultrason (2001)       Date:  2016-10-22       Impact factor: 1.314

6.  Hepatic focal nodular hyperplasia: contrast-enhanced ultrasound findings with emphasis on lesion size, depth and liver echogenicity.

Authors:  Tommaso Vincenzo Bartolotta; Adele Taibbi; Domenica Matranga; Giovanni Malizia; Roberto Lagalla; Massimo Midiri
Journal:  Eur Radiol       Date:  2010-04-21       Impact factor: 5.315

7.  Algorithm-based approach to focal liver lesions in contrast-enhanced ultrasound.

Authors:  Kheng Song Leow; Christine Ying Kwok; Hsien Min Low; Rahul Lohan; Tze Chwan Lim; Su Chong Albert Low; Cher Heng Tan
Journal:  Australas J Ultrasound Med       Date:  2022-07-04

8.  Research on focal nodular hyperplasia with MSCT and postprocessing.

Authors:  Yuan-Jian Liu; Wei-Jun Fan; Zhi-Dong Yuan; Peng-Cheng Liu; Chun-Rong Wang; Wei-Qiang Yan; Su-Mei Wang; Jun-Hui Chen; Zheng Liu
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

9.  Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma.

Authors:  X-Q Pei; L-Z Liu; Y-H Xiong; R-H Zou; M-S Chen; A-H Li; M-Y Cai
Journal:  Br J Radiol       Date:  2013-02-07       Impact factor: 3.039

Review 10.  Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.

Authors:  Jae Young Jang; Moon Young Kim; Soung Won Jeong; Tae Yeob Kim; Seung Up Kim; Sae Hwan Lee; Ki Tae Suk; Soo Young Park; Hyun Young Woo; Sang Gyune Kim; Jeong Heo; Soon Koo Baik; Hong Soo Kim; Won Young Tak
Journal:  Clin Mol Hepatol       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.